You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.


EGFR and NSCLC Diagnostic Strategies: What Should You Know?


This live event has already occurred. The archived version of this activity will be available here within the next few weeks.

EGFR mutation status is important at the time of diagnosis of NSCLC and in patients whose disease has become refractory to EGFR tyrosine kinase inhibitors (TKIs). In both settings, mutation status can help direct treatment. The most common mechanism of tumor resistance to EGFR TKIs is the EGFR exon 20 p. T790M mutation. An emerging area of interest is the ability of liquid biopsy to detect activating EGFR mutations and to detect T790M EGFR mutations at the time of relapse. Understanding the latest developments in this field should help physicians provide the best care for their patients with NSCLC.

Join us on November 9, 2016, at 12:00 pm EST for a live, web-based CME event from the Association for Molecular Pathology 2016 Annual Conference in Charlotte, North Carolina, where an expert panel will discuss the importance of identifying EGFR mutations and testing for EGFR resistance mechanisms in patients with NSCLC and the latest biopsy techniques.

Laura J. Tafe, MD
Assistant Professor of Pathology
Assistant Director
Laboratory for Clinical Genomics and Advanced Technology
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire
Jared Weiss, MD
Assistant Professor
Division of Hematology-Oncology
Thoracic Oncology Program
University of North Carolina-Chapel Hill
Chad A. Livasy, MD
Carolinas Pathology Group
Carolinas Medical Center
Adjunct Professor
University of North Carolina-Chapel Hill

Prior to the live webcast event, please check that your system requirements allow you to view the program:

If you are unable to access this test event, please contact your IT department for additional assistance.

  • Print